CLINICAL STUDY
Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care
Soccorso Capomolla, MD*,*,
Oreste Febo, MD*,
Monica Ceresa, MD*,
Angelo Caporotondi, MD*,
Giampaolo Guazzotti, MD*,
Maria Teresa La Rovere, MD*,
Marina Ferrari, NS*,
Francesca Lenta, NS*,
Sonia Baldin, NS*,
Chiara Vaccarini, MD*,
Marco Gnemmi, MD*,
GianDomenico Pinna, MS*,
Roberto Maestri, MS*,
Paola Abelli, MD*,
Sandro Verdirosi, MD* and
Franco Cobelli, MD*
* Fondazione "Salvatore Maugeri," IRCCS, Dipartimento di Cardiologia, Istituto Scientifico di Montescano, Montescano, Pavia, Italy
Manuscript received December 28, 2001;
revised manuscript received May 13, 2002,
accepted June 27, 2002.
* Reprint requests and correspondence: Dr. Soccorso Capomolla, Department of Cardiology, Montescano Medical Center, Via per Montescano, 27040 Montescano, Pavia, Italy. scapomolla{at}fsm.it
OBJECTIVES: This study compared the effectiveness and cost/utility ratio between a heart failure (HF) management program delivered by day-hospital (DH) and usual care in chronic heart failure (CHF) outpatients.
BACKGROUND: Previous studies showed that about 50% of readmissions for CHF can be prevented by a multidisciplinary approach However, the performance, effectiveness, and cost/utility ratio of a process of HF outpatient management related to evidence-based medicine have not been considered.
METHODS: A total of 234 prospective patients discharged by a HF Unit were randomized to two management strategies: 122 patients to usual community care and 112 patients to a HF management program delivered by the DH. Management (rate of readmissions, therapeutic interventions), functional parameters (New York Heart Association [NYHA] functional class, left ventricular diameters, and ejection fraction, deceleration time of early diastolic mitral flow, peak oxygen uptake, and mitral regurgitation) and hard outcomes (cardiac death and urgent cardiac transplantation) were evaluated. The cost/utility ratios of the two strategies were compared.
RESULTS: After 12 ± 3 months of follow-up, the individual rate access in DH was 5.5 ± 3.8 days. The DH subjects were readmitted to the hospital less frequently than were the usual-care group patients (13 vs. 78, p < 0.00001). Patients allocated to usual-care management showed heterogeneous changes in NYHA functional class (13% improved and 16% worsened p = NS); In contrast, the DH group showed significant changes in NYHA functional class (23% improved and 11% worsened, p < 0.009). Hard cardiac events in the one-year follow-up occurred in 25/234 (10.6%) patients; cardiac death occurred in 21/122 (17.2%) of the community group and in 3/112 (2.7%) in the DH group (p < 0.0007). One DH patient underwent urgent transplantation. Comparison of the two managerial models by Cox regression analysis showed that DH management significantly protected against the appearance of hard events (relative risk [RR] 0.17; confidence interval [CI] 0.06 to 0.66). The cost/utility ratio of the two management strategies was similar (usual care $2,409 vs. DH $2,244). The incremental analysis revealed a cost savings of $1,068 for each quality-adjusted life year gained. The cost/utility ratio for the integration of DH management of CHF was $19,462 (CI $13,904 to $34,048).
CONCLUSIONS: A heart failure outpatient management program delivered by a DH can reduce mortality and morbidity of CHF patients. This management strategy is cost-effective and has an equitable value from a societal point of view.
|
Abbreviations and Acronyms
| | ACE | | angiotensin-converting enzyme | | CHF | | chronic heart failure | | CI | | confidence interval | | DH | | day-hospital | | DRG | | diagnosis-related group | | EBM | | evidence-based medicine | | HF | | heart failure | | HFU | | Heart Failure Unit | | IV | | intravenous | | LVEF | | left ventricular ejection fraction | | NYHA | | New York Heart Association functional class | | QALY | | quality-adjusted life years | | RR | | relative risk | | Vo2 | | oxygen uptake |
|
This article has been cited by other articles:

|
 |

|
 |
 
D. E. Morisky, G. F. Kominski, A. A. Afifi, and J. B. Kotlerman
The Effects of a Disease Management Program on Self-Reported Health Behaviors and Health Outcomes: Evidence From the "Florida: A Healthy State (FAHS)" Medicaid Program
Health Educ Behav,
June 1, 2009;
36(3):
505 - 517.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Miller, S. Randolph, E. Forkner, B. Smith, and A. D. Galbreath
Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
Med Decis Making,
May 1, 2009;
29(3):
325 - 333.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Ezekowitz
What Price to Pay?: The Cost of Everything and the Value of Nothing
Circulation,
January 27, 2009;
119(3):
368 - 370.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W F B.-A. de la Porte, D. J A Lok, D. J van Veldhuisen, J. van Wijngaarden, J. H Cornel, N. P A Zuithoff, E. Badings, and A. W Hoes
Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study
Heart,
July 1, 2007;
93(7):
819 - 825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Liberato, M. Marchetti, and G. Barosi
Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
J. Clin. Oncol.,
February 20, 2007;
25(6):
625 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. McDonald, C. Conlon, and M. Ledwidge
Disease management programs for heart failure: Not just for the 'sick' heart failure population
Eur J Heart Fail,
February 1, 2007;
9(2):
113 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lainscak and I. Keber
Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinic
Eur J Heart Fail,
March 1, 2006;
8(2):
187 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Roccaforte, C. Demers, F. Baldassarre, K. K.Teo, and S. Yusuf
Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis
Eur J Heart Fail,
December 1, 2005;
7(7):
1133 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Grigorian Shamagian, J. R. Gonzalez-Juanatey, A. V. Roman, J. M. G. Acuna, and A. V. Lamela
The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period
Eur. Heart J.,
November 1, 2005;
26(21):
2251 - 2258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
GESICA Investigators
Randomised trial of telephone intervention in chronic heart failure: DIAL trial
BMJ,
August 20, 2005;
331(7514):
425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komajda, P. Lapuerta, N. Hermans, J. R. Gonzalez-Juanatey, D. J. van Veldhuisen, E. Erdmann, L. Tavazzi, P. Poole-Wilson, and C. Le Pen
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Eur. Heart J.,
August 2, 2005;
26(16):
1653 - 1659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ducharme, O. Doyon, M. White, J. L. Rouleau, and J. M. Brophy
Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial
Can. Med. Assoc. J.,
July 5, 2005;
173(1):
40 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Holland, J Battersby, I Harvey, E Lenaghan, J Smith, and L Hay
Systematic review of multidisciplinary interventions in heart failure
Heart,
July 1, 2005;
91(7):
899 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Havranek
Improving the Outcomes of Heart Failure Care: Putting Technology Second
J. Am. Coll. Cardiol.,
May 17, 2005;
45(10):
1665 - 1666.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Jaarsma
Health care professionals in a heart failure team
Eur J Heart Fail,
March 16, 2005;
7(3):
343 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Stewart
Financial aspects of heart failure programs of care
Eur J Heart Fail,
March 16, 2005;
7(3):
423 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Capomolla, G. Pinna, M. T. La Rovere, R. Maestri, M. Ceresa, M. Ferrari, O. Febo, A. Caporotondi, G. Guazzotti, F. Lenta, et al.
Heart failure case disease management program: a pilot study of home telemonitoring versus usual care
Eur. Heart J. Suppl.,
November 1, 2004;
6(suppl_F):
F91 - F98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gonseth, P. Guallar-Castillon, J. R. Banegas, and F. Rodriguez-Artalejo
The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports
Eur. Heart J.,
September 2, 2004;
25(18):
1570 - 1595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. McAlister, S. Stewart, S. Ferrua, and J. J.J.V. McMurray
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials
J. Am. Coll. Cardiol.,
August 18, 2004;
44(4):
810 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bundkirchen and R. H.G Schwinger
Epidemiology and economic burden of chronic heart failure
Eur. Heart J. Suppl.,
August 1, 2004;
6(suppl_D):
D57 - D60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. O. Phillips, S. M. Wright, D. E. Kern, R. M. Singa, S. Shepperd, and H. R. Rubin
Comprehensive Discharge Planning With Postdischarge Support for Older Patients With Congestive Heart Failure: A Meta-analysis
JAMA,
March 17, 2004;
291(11):
1358 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sendi
Cost-effectiveness of a heart failure management program from the societal perspective?
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1850 - 1850.
[Full Text]
[PDF]
|
 |
|
|